Brind.

AngioDynamics is classified in the Medical Instruments Industry and has been underperforming the market so far this year.

1 report, 1 independent Updated Jul 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

AngioDynamics is classified in the Medical Instruments Industry and has been underperforming the market so far this year.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • ZacksAngioDynamics (ANGO) Reports Q4 Loss, Tops Revenue Estimates AngioDynamics (ANGO) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.13. This compar